Interact to see
Advertisement
Advertisement
FSMAX vs HMDYX
FSMAX vs HMDYX Comparison
Open Charts FSMAX vs HMDYX
Fidelity Extended Market Index
Price$98.68
Change-$2.68 (-2.64%)
VolumeN/A
Net Assets41.46B
FSMAX vs HMDYX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FSMAX vs. HMDYX commentary
Nov 14, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and HMDYX is a Hold.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.5B vs. HMDYX (4.21B). FSMAX pays higher dividends than HMDYX: FSMAX (0.43) vs HMDYX (0.00). FSMAX was incepted earlier than HMDYX: FSMAX (14 years) vs HMDYX (28 years). HMDYX (0.86) is less costly to investors than FSMAX (0.04). HMDYX is a more actively managed with annual turnover of: 51.00 vs. FSMAX (15.00). FSMAX has a lower initial minimum investment than HMDYX: FSMAX (0) vs HMDYX (250000). FSMAX annual gain was more profitable for investors over the last year : 7.45 vs. HMDYX (-9.69). FSMAX return over 5 years is better than : 44.70 vs. HMDYX (-19.66).
| FSMAX | HMDYX | FSMAX / HMDYX | |
| Total Expense Ratio | 0.04 | 0.86 | 4% |
| Annual Report Gross Expense Ratio | 0.04 | 0.86 | 4% |
| Fund Existence | 14 years | 28 years | - |
| Gain YTD | 11.532 | -1.898 | -608% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 41.5B | 4.21B | 986% |
| Annual Yield % from dividends | 0.43 | 0.00 | - |
| Returns for 1 year | 7.45 | -9.69 | -77% |
| Returns for 3 years | 55.42 | 1.73 | 3,204% |
| Returns for 5 years | 44.70 | -19.66 | -227% |
| Returns for 10 years | 106.36 | 13.40 | 794% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PRHSX | 90.91 | -0.46 | -0.50% |
| T. Rowe Price Health Sciences | |||
| EPSRX | 25.24 | -0.28 | -1.10% |
| NYLI Epoch Global Equity Yield Class R6 | |||
| IRPSX | 10.51 | -0.12 | -1.13% |
| VY® T. Rowe Price Equity Income S | |||
| PMPRX | 15.77 | -0.18 | -1.13% |
| Principal MidCap Value I R3 | |||
| LPFCX | 5.29 | -0.13 | -2.40% |
| ALPS Global Opportunity C | |||